(1)
REVIEW OF CURRENT GUIDELINES AND STUDIES ON USE OF ACETYLSALICYLIC ACID IN THE PRIMARY CARDIOVASCULAR EVENTS PREVENTION. Prospect. Pharm. Sci. 2019, 17 (4), 20-23. https://doi.org/10.56782/pps.29.